Healthcare-focused private equity firm Apposite Capital is set to generate a 20-times return on the sale of a US provider of non-surgical facelift devices to pharmaceutical group Merz.

The deal comes as the medical sector heats up, reflected by a rise in the number of specialist healthcare-related buyout firms launching in Europe over the past year.